Startseite>>Signaling Pathways>> Angiogenesis>> Integrin>>Integrin modulator 1

Integrin modulator 1

Katalog-Nr.GC61613

Integrin-Modulator 1 ist ein potenter und selektiver α4β1-Integrin-Agonist mit einer IC50 von 9,8 nM fÜr RGD-bindendes α4β1.

Products are for research use only. Not for human use. We do not sell to patients.

Integrin modulator 1 Chemische Struktur

Cas No.: 2023788-32-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
357,00 $
Auf Lager
5 mg
324,00 $
Auf Lager
10 mg
538,00 $
Auf Lager
25 mg
1.020,00 $
Auf Lager
50 mg
1.576,00 $
Auf Lager
100 mg
2.318,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Integrin modulator 1 is a potent and selective α4β1 integrin agonist, with an IC50 of 9.8 nM for RGD-binding α4β1. Integrin modulator 1 increases cell adhesion mediated by α4β1 integrin, with an EC50 of 12.9 nM[1].

Integrin modulator 1 (2-10 μg/mL; 30 min) significantly increases Jurkat E6.1 cell adhesion[1].Integrin modulator 1 (1-100 nM; 1 h) strongly and significantly increases ERK1/2 phosphorylation in Jurkat E6.1 cells[1].Integrin modulator 1 (1 nM-10 μM; 30 min) significantly increases the binding of HUTS-21 antibody to Jurkat E6.1 cells in a concentration-dependent manner[1].

[1]. Baiula M, et, al. New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins. J Med Chem. 2016 Nov 10;59(21):9721-9742.

Bewertungen

Review for Integrin modulator 1

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Integrin modulator 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.